HHS Priorities for 2022
Looking at 2022 the HHS reported its regulatory and deregulatory rule proposals for inclusion in the Administrations unified agenda released in December. We take a look at the ONC, CMS, and HRSA agencies under HHS.
Read MoreLooking at 2022 the HHS reported its regulatory and deregulatory rule proposals for inclusion in the Administrations unified agenda released in December. We take a look at the ONC, CMS, and HRSA agencies under HHS.
Read MoreCMS is accepting stakeholders’ recommendations regarding potential new specialty measure sets and/or revisions to existing specialty measure sets for the 2023 performance year of MIPS. Recommendations for new specialty sets or revisions to the 2022 specialty sets should be based on the established 2022 MIPS quality measures.
By Julie Appleby – Maybe this has happened to you recently: Your doctor telephoned to check in with you, chatting for 11 to 20 minutes, perhaps answering a question you contacted her office with, or asking how you’re responding to a medication change. For that, your doctor got paid about $27 if you are on Medicare — maybe a bit more if you have private insurance.
By Chiquita Brooks-LaSure – The COVID-19 pandemic exposed many shortcomings in our health care system, especially the ability to quickly share and use reliable data to better understand the health needs of all people across the country.
Watch our series of webinars on value-based care. CMS has released the 2022 QPP final rule with Matt Fusan and Erica Arias to discuss the coming changes to the MIPS program and the latest developments related to the APM Performance Pathway program.
CMS opened the Doctors and Clinicians Preview Period on November 15, 2021. The Preview Period provides an opportunity for doctors and clinicians to review their 2020 QPP performance information before it’s publicly reported on clinician and group profile pages on Medicare Care Compare and in the Provider Data Catalog.
CMS is hosting a webinar on Tuesday, December 7 from 12:30 – 2:00 p.m. ET to provide an overview of MIPS Value Pathways (MVPs) development for the 2023 performance year of the Quality Payment Program and beyond.
CMS continues to provide relief where possible to clinicians responding to the 2019 COVID-19 public health emergency. They are applying the Merit-based Incentive Payment System automatic extreme and uncontrollable circumstances policy to ALL individually eligible MIPS eligible clinicians for the 2021 performance year.
Latest announcements made from companies and organizations on hiring, appointments and who is hiring include Kaia Health, Volastra Therapeutics, 1upHealth, CHIME, Civitas Networks, Onix, EHNAC, Implicity, AVIA, Wolters Kluwer, Activ Surgical, CMS, Trusted Health, Sphere & more.